Global Myopia Control Management in Children and Teenagers Market Strategic Research Report

Scope of the Report

The global Myopia Control Management in Children and Teenagers market size is predicted to grow from US$ 1,821 million in 2025 to US$ 5,003 million in 2032; it is expected to grow at a CAGR of 15.2% from 2026 to 2032.

Myopia control aims to slow down the progression or worsening of myopia in children and teenagers, so that their final amount of myopia is less than what it would have been without treatment.

Myopia control is important to both improve your child or teenagers' vision with less frequent changes in prescription in childhood, as well as reducing their lifelong risk of eye diseases and vision impairment associated with higher levels of myopia.

Myopia control treatments include special types of spectacle lenses, soft contact lenses, ortho-k and atropine eye drops.

Myopia Control Management in Children and Teenagers is a specialized eye health product market focused on interventions to slow myopia progression in children and teenagers. Its core objective is not simply to correct vision, but to delay the progression of myopia and axial elongation through specific optical designs, corneal reshaping, contact lens defocus designs, or low-dose pharmaceutical intervention. The scope of this study covers only four product categories: myopia control spectacle lenses, orthokeratology lenses, multifocal or defocus-designed soft contact lenses, and low-dose atropine eye drops.

Among these products, myopia control spectacle lenses are currently the most widely adopted category, with relatively low usage barriers. These lenses use multi-zone defocus, micro-lens arrays, peripheral defocus, or special optical zone designs to provide clear vision correction while generating myopic defocus signals on the retina, thereby helping to slow myopia progression. They are suitable for most children and teenagers in daily study, outdoor activities, and long-term wearing scenarios. Representative products include HOYA MiYOSMART, ZEISS MyoCare/MyoVision, and Essilor Stellest.

Orthokeratology lenses are another important product category for myopia control. They are typically worn overnight to temporarily reshape the anterior corneal surface, allowing children to achieve relatively clear unaided vision during the day while also creating a certain peripheral defocus effect to control myopia progression. These products have relatively high unit prices and require professional fitting expertise, regular follow-up, strong care compliance, and suitable corneal conditions. They are mainly used in hospital ophthalmology departments, professional optometry centers, and high-end vision care institutions.

Multifocal or defocus-designed soft contact lenses mainly include daily disposable, monthly disposable, and customized soft contact lens products. Through multifocal, concentric-ring, EDOF, or other defocus designs, these lenses provide daytime vision correction while supporting myopia management. This product category has gained certain adoption in markets such as Europe, the United States, Japan, and Australia. Representative products include CooperVision MiSight 1 day, Johnson & Johnson Abiliti 1-Day, SEED 1dayPure EDOF, and Mark’ennovy MYLO. However, approved indications, sales channels, and prescribing habits vary across different countries and regions.

Low-dose atropine eye drops are a pharmaceutical intervention product for myopia control. They are mainly used through long-term administration of low-dose atropine to slow myopia progression in children and teenagers. These products usually require a doctor’s prescription and rely on regular follow-up and medication compliance management. Around 2025, commercialized or approved products gradually emerged in markets such as China, Japan, Australia, India, and Europe. Representative companies include Xingqi Ophthalmic Medicine, Santen, Aspen, and ENTOD Pharmaceuticals. Compared with spectacle lenses and orthokeratology lenses, low-dose atropine eye drops are still in the early stage of market introduction, with relatively low penetration. However, with the increase in approved products, the improvement of concentration gradients, and rising acceptance among doctors, this category still has certain growth potential.

This report presents a comprehensive overview of the global Myopia Control Management in Children and Teenagers market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Spectacles for Myopia Control
• Soft Contact Lenses for Myopia Control
• Ortho-k Contact Lenses
• Atropine Eye Drops

Segment by Sales Channel

• Eye Hospital
• Eye Clinic
• Brand Store
• Eyewear Retail Store
• Online Sales

Segment by Application

• Children
• Teenagers

Segment by Application

• Daily Learning
• Near-work/Screen Use
• Outdoor Activities
• Nighttime Intervention

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Myopia Control Management in Children and Teenagers market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Daily Learning, Near-work/Screen Use, Outdoor Activities evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact